GRI Bio, Inc.

GRI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
CORRESP Jun 5, 2023
UPLOAD Jun 5, 2023
S-3 May 30, 2023 S-3
ARS May 26, 2023 ARS
DEFA14A May 26, 2023 DEFA14A
DEF 14A May 26, 2023 DEF 14A
8-K/A May 26, 2023 8-K/A
10-Q May 15, 2023 10-Q
SC 13G May 3, 2023 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
SC 13G May 2, 2023
D Apr 27, 2023
8-K Apr 27, 2023 8-K
8-K Apr 27, 2023 8-K
SC 13D Apr 25, 2023 SC 13D
SC 13D Apr 25, 2023 SC 13D
SC 13D Apr 25, 2023 SC 13D
3 Apr 25, 2023 FORM 3
3 Apr 25, 2023 FORM 3
3 Apr 25, 2023 FORM 3
3 Apr 25, 2023 FORM 3
3 Apr 25, 2023 FORM 3
4 Apr 24, 2023 FORM 4
4 Apr 24, 2023 FORM 4
4 Apr 24, 2023 FORM 4
3 Apr 24, 2023 FORM 3
← Newer Page 10 of 17 · 401 filings Older →